型号规格:有3.75mg/7.5mg/15mg三种规格,每瓶100片。 药品详情: 【二钾氯氮Clorazepate Dipotassium(氯卓酸钾)简述】 二钾氯氮又名安定羧酸钾盐,氯氮卓二钾,氯草酸二钾,Belseren,DikaliiClorazepas,Tranxeneo(氯卓酸钾),英文名Clorazepate Dipotassium,是一类具有强镇静催眠作用的精神类药品。 【二钾氯氮Clorazepat...
Dipotassium clorazepate was administered intraperitoneally in rats that showed two stable stage 5 seizures induced at the GST current intensity. Dipotassium clorazepate at doses of 1 mg/kg or more produced an anticonvulsant effect, but did not readily suppress limbic seizures. Dipotassium clorazepate ...
(mg) of clorazepate dipotassium for assay containers and storagecontainersótight containers. clotiazepamクロチアゼパム c 16 h 15 cln 2 os: 318.82 5-(2-chlorophenyl)-7-ethyl-1-methyl-1,3-dihydro-2 h- thieno[2,3- e][1,4]-diazepin-2-one [ 33671-46-4] clotiazepam, when dried, ...
Clorazepate dipotassium with cas registry number of 57109-90-7 is also known as Clorazepate Dipotassium [USAN:JAN] ; 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide ; 1H-1,4-Benzodiazepine-3-carboxylic acid,...
Clorazepate Dipotassium CIV (125 mg) Clorazepate dipotassium salt solution cm4306 clorazepatedipotassium chlorazepatedipotassium chlorazepate Potassium hydroxide, compd. with 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid monopotassium salt (1:1) Potassium hydroxide...
产品编号:1140509查看说明书 产品名称:Clorazepate Dipotassium CIV (125 mg) .0订购此产品 供应商:USP 规格:*** 目录价:4275 库存状态: CAS编号: 应用范围: 种属来源: 相关信息: 保存条件: 说明书地址:点击查看详细 打印此页关闭此页 上一个:Clopidogrel Bisulfate (125 mg)[1140430/***] ...
日本橙皮书数据库提供Mendon Cap. 7.5mg药物的基本信息,包括日文名称クロラゼプ酸二カリウム,通用名Clorazepate Dipotassium,中文名氯䓬酸钾,Mendon Cap. 7.5mg的活性成分,剂型,规格,产品特征,药效分类,企业名称Abbott Japan Co., Ltd.以及4条溶出曲线,溶出条件等信息.
Clorazepate Dipotassium CIV (125 mg),Clorazepate Dipotassium CIV (125 mg),57109-90-7,供应厂家CATO标准品。提供标准品,对照品价格等详细信息:
List of United States Pharmacopoeia (USP) Analytical Reference Standards of Clorazepate Dipotassium and Related Impurities
Twenty-four dogs were given clorazepate dipotassium orally in a 22-month toxicity study; doses up to 75 mg/kg were given. Drug-related changes occurred in the liver; weight was increased andcholestasiswith minimal hepatocellular damage was found, but lobular architecture remained well preserved. ...